Skip to navigation menu Skip to content
Jump to:  A   |   B   |   C   |   D   |   E   |   F   |   G   |   H   |   I   |   J   |   K   |   L   |   M   |   N   |   O   |   P   |   Q   |   R   |   S   |   T   |   U   |   V   |   W   |   X   |   Y

Gene Therapy May Reverse Hurler Syndrome, a Rare and Severe Illness in Kids

Gene Therapy May Reverse Hurler Syndrome, a Rare and Severe Illness in Kids

THURSDAY, Nov. 18, 2021 (HealthDay News) -- Gene therapy might soon offer a new option for children with a rare genetic disorder that damages tissues throughout the body, researchers are reporting.

In a study of eight children with the condition, called Hurler syndrome, researchers found that the gene therapy was safe over two years. It also showed potential for beating the current standard treatment, stem cell transplantation.

If the gene therapy proves safe and effective in the longer term, experts said, it may well replace stem cell transplants in the future.

"I do think this is a triumph," said Dr. Christopher Dvorak, who co-wrote an editorial published with the study Nov. 18 in the New England Journal of Medicine.

"It's likely to change lives in the not-too-distant future," said Dvorak, a specialist in pediatric stem cell transplantation at the University of California, San Francisco.

Hurler syndrome is one of about 50 genetic diseases known as lysosomal disorders, where children are born lacking key enzymes needed for body cells to function normally.

Hurler syndrome arises when a child inherits a flawed copy of a gene called IDUA from each parent.

The IDUA gene governs an enzyme that breaks down certain complex sugars. In children with Hurler syndrome, those sugars accumulate in cells, causing damage throughout the body, including the brain, eyes, heart and bones.

Enzyme replacement therapy can help with some of those issues, but it does not cross into the brain, said Dr. Walla Al-Hertani, director of the lysosomal disease program at Boston Children's Hospital.

So doctors have turned to stem cell transplants.

The process involves using chemotherapy to deplete a child's own blood-forming stem cells, and replacing them with healthy stem cells from a donor, often from umbilical cord blood. Those healthy cells provide a supply of the needed enzyme, including into the brain.

However, there are downsides.

Even after a transplant, both eye and joint disease can continue to worsen because those areas have a lesser blood supply, explained Al-Hertani, who was not involved in the new study.

And because the treatment involves donor cells, there is a risk of serious immune system reactions, which means ongoing immune-suppressing medication.

Gene therapy could potentially address those issues. For the new study, an international research team tested the approach in eight children with Hurler syndrome, who were about 2 years old, on average.

The tactic involved removing a sample of the children's own blood-forming stem cells, then using a safety-modified virus to deliver a functioning IDUA gene to the cells. After the children had chemotherapy to deplete their remaining blood stem cells, the gene-corrected cells were infused back into their bodies.

Within a month, the researchers found, the children were showing high IDUA activity in their blood — three to 12 times higher than what's seen in healthy donors — and a sharp reduction in abnormal sugar accumulation.

That high IDUA activity is key,according to lead researcher Dr. Bernhard Gentner of San Raffaele Hospital in Milan, Italy.

Gentner said it suggests that gene therapy might allow more efficient "cross correction" of cells in various body tissues, including the bones — where stem cell transplantation is not effective.

At this point, Gentner's team reports, the children have shown normal growth, and are stable in their learning and thinking skills, and stable or "improved" in imaging of the brain and spine.

Al-Hertani said the children need to be followed longer to see whether their enzyme activity remains high, and whether the gene therapy is, in fact, more effective than standard transplants.

But in general, Al-Hertani said she believes gene therapy is "the future" when it comes to treating these rare genetic disorders.

"Our goal," Gentner said, "is to make this new treatment available to patients as soon as possible."

To that end, he added, U.K.-based Orchard Therapeutics has been granted a license to further develop the gene therapy. A phase 2 study is in the "advanced" planning stages, Gentner said.

Dvorak said he does have some concerns about equitable availability should gene therapy become a standard treatment for Hurler syndrome.

In theory, any medical center that treats the condition should be able to offer gene therapy. But it's possible it will roll out in a more limited way, according to Dvorak.

"It's also going to be quite pricey," he said. "I do have concerns that there could be socioeconomic disparities in access to it."

Hurler syndrome affects an estimated one in 100,000 newborns, according to the U.S. National Institutes of Health. The disorder is part of newborn screening in some U.S. states, Dvorak said, but not all.

More information

Boston Children's Hospital has more on Hurler syndrome.

SOURCES: Bernhard Gentner, MD, hematologist, stem cell transplantation unit, San Raffaele Hospital, Milan, Italy; Walla Al-Hertani, MD, MSc, director, lysosomal disease program, Boston Children's Hospital, assistant professor, pediatrics, Harvard Medical School, Boston; Christopher Dvorak, MD, chief, pediatric allergy, immunology and bone marrow transplant division, Benioff Children's Hospitals, University of California, San Francisco; New England Journal of Medicine, Nov. 18, 2021

Reviewed Date: --

This content was reviewed by Mid-Atlantic Womens Care, PLC. Please visit their site to find an Mid-Atlantic Womens Care obstetrician.

Find a pediatrician
Helpful Information
Mid-Atlantic Womens's Care
Allergy, Asthma and Immunology
Dr. Clinton Dunn
Dr. Angela Duff Hogan
Dr. Kelly Maples
Dr. Lindsey Moore
Dr. Maripaz Morales
Dr. Lauren Smith
Health Tips
Helping Kids Get Over their Fears
Is It Time for Toilet Training?
Reading to Kids Helps Their Development
Sports and Music: Both Good for Kids
Weight Room No Longer Off-Limits to Kids
When Can a Child Wear Contact Lenses
Birth Defects Quiz
Child Development Quiz
Diseases & Conditions
Anatomy of a Child's Brain
Anatomy of the Endocrine System in Children
Anorectal Malformation in Children
Anxiety Disorders in Children
Asthma in Children Index
Becker Muscular Dystrophy (BMD) in Children
Birth Defects in Children
Bone Marrow Transplant for Children
Brain Tumors in Children
Branchial Cleft Abnormalities in Children
Chemotherapy for Children: Side Effects
Clubfoot in Children
Congenital Heart Disease
Cystic Fibrosis Overview
Ewing Sarcoma in Children
Hepatitis B Virus (HBV) in Children
Identification, Treatment, and Prevention of Birth Defects
Inflammatory and Infectious Musculoskeletal Disorders
Inflammatory and Infectious Neurological Disorders
Inguinal Hernia in Children
Insect Bites and Children
Kidney Transplantation in Children
Medical Genetics: DNA Studies for Single Gene Defects
Medical Genetics: Treatment with Gene and Enzyme Replacement Therapy
Medical Genetics: Types of Genetic Changes
Meningitis in Children
Mood Disorders in Children and Adolescents
Myasthenia Gravis (MG) in Children
Osteosarcoma (Osteogenic Sarcoma) in Children
Pediatric Blood Disorders
Physical Abnormalities
Posttraumatic Stress Disorder (PTSD) in Children
Preparing the School-Aged Child for Surgery
Schizophrenia in Children
School-Aged Child Nutrition
Single Gene Defects
Sports Safety for Children
Superficial Injuries of the Face and Head- Overview
Support Groups
Television and Children
Testing for Birth Defects
The Growing Child: 1 to 3 Months
The Growing Child: 10 to 12 Months
The Growing Child: 2-Year-Olds
The Growing Child: 4 to 6 Months
The Growing Child: 7 to 9 Months
The Growing Child: Newborn
The Growing Child: Preschool (4 to 5 Years)
The Growing Child: School-Age (6 to 12 Years)
The Heart
The Kidneys
Your Child's Asthma
Your Child's Asthma: Flare-ups

Disclaimer: This information is not intended to substitute or replace the professional medical advice you receive from your child's physician. The content provided on this page is for informational purposes only, and was not designed to diagnose or treat a health problem or disease. Please consult your child's physician with any questions or concerns you may have regarding a medical condition.